Products for Research Use Only
RegisterLogin

Cadonilimab

CAT: 0931-T76716-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T76716-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
2394841-59-7
Target
PD-1/PD-L1, Immunology/Inflammation related, COX, IL Receptor
Related Pathways
Neuroscience, Apoptosis, Immunology/Inflammation, Cell Cycle/Checkpoint
Purity
0.95
Bioactivity
Cadonilimab (AK104) is a tetravalent PD-1/CTLA-4 bispecific humanised antibody that activates T cells by enhancing IL-2 and IFN-γ secretion while reducing pro-inflammatory cytokine secretion (e.g., IL-6, IL-8) . It offers low toxicity and high affinity, making it suitable for metastatic cervical, gastric, hepatic, and pulmonary cancers, pancreatic cancer, and oesophageal squamous cell carcinoma.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Alternative Products

CatalogName
abx831613-01Cadonilimab
GTR18337562-01Cadonilimab Antibody
HS870216-01Research Grade Cadonilimab
E55B1268Cadonilimab (Reference antibody)
ICH5208-20mgCadonilimab Biosimilar - Research Grade
21-891Cadonilimab - Research Grade Biosimilar
GTR18697395-01Cadonilimab Human Monoclonal Antibody
591731-01PD-1xCTLA-4, Cadonilimab Biosimilar
C00868Cadonilimab (Anti-PD-1 & CTLA-4)
F2106-5Anti-PD-1 /CTLA-4 Antibody (Cadonilimab)

Popular Products